Change search
ReferencesLink to record
Permanent link

Direct link
Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial
National Board of Health and Welfare, Stockholm, Sweden.
Show others and affiliations
2008 (English)In: Clinical trials (London, England), ISSN 1740-7745, Vol. 5, no 4, 308-315 p.Article in journal (Refereed) Published
Abstract [en]

With new NIH requirements for data-sharing, the frequency of re-analysis of clinical trial data may increase substantially. This re-evaluation provides a blueprint for future re-evaluations of other trials. These best practices include re-analysis of the study data, after suitable replication, by an independent multidisciplinary committee, including a skilled statistical programmer analyst. Primary investigators should address significant errors determined in such re-analyses.

Place, publisher, year, edition, pages
2008. Vol. 5, no 4, 308-315 p.
URN: urn:nbn:se:umu:diva-41424DOI: 10.1177/1740774508094404PubMedID: 18697845OAI: diva2:406020
Available from: 2011-03-24 Created: 2011-03-24 Last updated: 2011-03-25Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Asplund, Kjell

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 34 hits
ReferencesLink to record
Permanent link

Direct link